These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 17003775)

  • 21. [Radiotherapy for PSA failure after prostatectomy: which volumes?].
    Bosset M; Maingon P; Bosset JF
    Cancer Radiother; 2006 May; 10(3):117-23. PubMed ID: 16300980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The PSA era is not over for prostate cancer.
    Catalona WJ; Loeb S
    Eur Urol; 2005 Oct; 48(4):541-5. PubMed ID: 16139417
    [No Abstract]   [Full Text] [Related]  

  • 23. Fundamentals on the pathology of prostatic carcinoma after brachytherapy.
    Helpap B
    World J Urol; 2002 Sep; 20(4):207-12. PubMed ID: 12215847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The latest strategies for treating prostate cancer.
    Johns Hopkins Med Lett Health After 50; 2001 Mar; 13(1):4-5. PubMed ID: 11232479
    [No Abstract]   [Full Text] [Related]  

  • 25. Current role of prostate-specific antigen kinetics in managing patients with prostate cancer.
    Teahan SJ; Klotz LH
    BJU Int; 2006 Mar; 97(3):451-5. PubMed ID: 16469006
    [No Abstract]   [Full Text] [Related]  

  • 26. [Prostate carcinoma--a tumor with many open questions].
    Hofstetter A
    Fortschr Med; 1991 Sep; 109(26):509-11. PubMed ID: 1783342
    [No Abstract]   [Full Text] [Related]  

  • 27. [Prostate-specific antigen in the diagnosis and treatment of carcinoma of the prostate].
    Cerović S; Dimitrijević J; Milović N; Ajdinović B; Knezević-Usaj S; Popović L; Brajusković G
    Vojnosanit Pregl; 2002; 59(6 Suppl):53-7. PubMed ID: 12852147
    [No Abstract]   [Full Text] [Related]  

  • 28. Solitary fibrous tumor of the prostate a report of 2 cases and review of the literature.
    Pins MR; Campbell SC; Laskin WB; Steinbronn K; Dalton DP
    Arch Pathol Lab Med; 2001 Feb; 125(2):274-7. PubMed ID: 11175651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prostatic cancer before the age of 50. Diagnostic and therapeutic considerations].
    Aubert J
    Rev Med Suisse Romande; 1992 Sep; 112(9):769-73. PubMed ID: 1411036
    [No Abstract]   [Full Text] [Related]  

  • 30. [The course of prostatic carcinoma].
    Meinhardt W; Horenblas S; Newling DW
    Ned Tijdschr Geneeskd; 1995 Jun; 139(25):1271-5. PubMed ID: 7609801
    [No Abstract]   [Full Text] [Related]  

  • 31. Prostate-specific antigen adjusted for total prostatic tumor volume as a predictor for outcome after radical prostatectomy.
    Hayashi N; Urashima M; Ikemoto I; Kuruma H; Arai Y; Kuwao S; Baba S; Egawa S
    Prostate Cancer Prostatic Dis; 2007; 10(1):60-5. PubMed ID: 17003775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Global update on defining and treating high-risk localized prostate cancer with leuprorelin: a USA perspective--identifying men at diagnosis who are at high risk of prostate cancer death after surgery or radiation therapy.
    D'Amico A
    BJU Int; 2007 Jan; 99 Suppl 1():13-6; discussion 17-8. PubMed ID: 17229162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic markers under watchful waiting and radical prostatectomy.
    Holmberg L; Bill-Axelson A; Garmo H; Palmgren J; Norlén BJ; Adami HO; Johansson JE;
    Hematol Oncol Clin North Am; 2006 Aug; 20(4):845-55. PubMed ID: 16861118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cancer of the prostate stage T1. Incidental carcinoma. Review of the literature and an appraisal of the classification].
    Leisinger HJ
    Ann Urol (Paris); 1994; 28(4):229-34. PubMed ID: 7979213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Staging of prostatic cancer before and after radical prostatectomy].
    Pushkar' DIu; Bernikov AN; Bormotin AV
    Urologiia; 2003; (4):60-8. PubMed ID: 12942732
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.